I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Seroconversion Rate After SARS-CoV-2 Infection and Two Dose..:
Narayan Prasad
;
Shyam Bihari Bansal
;
Brijesh Yadav
...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.911738/full. , 2022
Link:
https://doi.org/10.3389/fimmu.2022.911738
RT Journal T1
Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:9815ce5cc1c84760bc62a79026ff7e1e&Exemplar=1&LAN=DE A1 Narayan Prasad A1 Shyam Bihari Bansal A1 Brijesh Yadav A1 Neha Manhas A1 Deependra Yadav A1 Sonam Gautam A1 Ravishankar Kushwaha A1 Ankita Singh A1 Dharmendra Bhadauria A1 Monika Yachha A1 Manas Ranjan Behera A1 Anupama Kaul PB Frontiers Media S.A. YR 2022 K1 vaccination K1 anti- SARS-CoV-2 antibody K1 humoral immunity K1 COVISHIELD™ K1 COVAXIN™ K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2022.911738/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2022.911738 DO https://doi.org/10.3389/fimmu.2022.911738 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)